FOXA2 and hepatocellular carcinoma: Mechanistically, FOXA2 overexpression enhanced the inhibitory effect of lenvatinib on HCC cells by up-regulating the AMPK-mTOR pathway and promoting autophagy in lenvatinib-treated HCC cells [134].